NCT03727334

Brief Summary

The goal of this study is to establish the feasibility of an intervention designed to improve memory in patients who have experienced a moderate or severe traumatic brain injury (m-sTBI) and to examine its effect on brain structures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

November 1, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

July 25, 2019

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

3.9 years

First QC Date

October 3, 2018

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Online Spatial Navigation Intervention Test Scores: Change in Spatial Learning Ability

    Participants complete online spatial navigation training 5 days per week for 16 weeks. Improvement in spatial learning ability will be assessed based on the accuracy of answers to questions regarding the reproduction of spatial elements, the direction and proximity of certain landmarks, and describing the most efficient route from point A to point B. Improvement will be assessed at the end of each week and at the end of the intervention. The raw scores range from 0-15, with higher scores indicating better spatial learning ability.

    Time-point 1: 7 months post-injury and Time-point 2: 12 months post-injury

  • Online Spatial Navigation Intervention Test Scores: Change in Cognitive Map Formation

    Participants complete online spatial navigation training 5 days per week for 16 weeks. Improvement in cognitive map formation will be assessed based on the number of trails required by the participant to learn landmark placements and based on the accuracy of the participant's navigation to a specific destination. The raw scores range from 1-21 and 0-10, respectively. A decrease in the number of trials required by the participant and an increase in navigation accuracy both correspond to an improvement in cognitive map formation.

    Time-point 1: 7 months post-injury and Time-point 2: 12 months post-injury

  • Online Spatial Navigation Intervention Test Scores: Change in Pattern Separation

    Measurement of pattern separation abilities are assessed in a task requiring the participant to differentiate memories in order to prevent interference from overlapping details. The following three variables are taken into account: i) percent correct ii) the discriminating value and iii) bias metric. Percent correct and bias metric are given as a percentage values (e.g., 80.63%) and the discriminating variable is given as a raw rate (e.g., 0.67). An improvement in pattern separation abilities are determined by an increase in percent correct and discrimination values from pre- to post-intervention. An increase in bias metric from pre- to post-intervention reflects an increased tendency for pattern separation.

    Time-point 1: 7 months post-injury and Time-point 2: 12 months post-injury

  • Online Spatial Navigation Intervention Test Scores: Change in Pattern Completion

    Measurement of pattern completion abilities are assessed in a task designed to probe pattern completion by presenting partial retrieval cues at different levels of degradation. The following variables are taken into account: i) accuracy for learned stimuli given as a percentage value (i.e., correctly selecting the name of the scene) ii) accuracy for new stimuli given as a percentage value (i.e., correctly indicating the stimuli is novel) and iii) bias measure. The bias measure is obtained by subtracting the learned stimuli accuracy score from the new stimuli accuracy score. An increase for both accuracy measures from pre- to post-intervention corresponds to improvement on recognition memory. An increase in bias measure reflects an increased tendency for pattern separation.

    Time-point 1: 7 months post-injury and Time-point 2: 12 months post-injury

Secondary Outcomes (2)

  • Neuronal injury biomarker predictors in serum and plasma samples

    Time-point 1: 7 months post-injury and Time-point 2: 12 months post-injury

  • Gliosis and inflammation biomarker predictors in serum samples

    Time-point 1: 7 months post-injury and Time-point 2: 12 months post-injury

Study Arms (2)

Treatment

EXPERIMENTAL

For the treatment arm, the participants will complete the intervention protocol following the first in-person study visit 7 months post-injury. The intervention involves 16 weeks of online, in-home spatial navigation training. During the 16 weeks, the participant will complete exercises for 1 hour/day, 5 days a week.

Behavioral: Online Spatial Navigation Training

Control

NO INTERVENTION

The control arm participants will receive their typical standard of care; they will not complete the intervention but will complete all of the in-person visits at the same post-injury time-points as the treatment group.

Interventions

Participants complete training tasks that test their spatial navigational abilities, cognitive map formation, and pattern separation. These training tasks involve map drawing, vector mapping, proximity judgments, and navigating with blocked routes.

Treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • An acute care diagnosis of TBI as determined by a medical professional, indicated by:
  • Post-traumatic amnesia duration of 24 hours or more, and/or lowest Glasgow Coma Scale score of \< 13
  • Positive clinical CT or MRI scan
  • Aged 18 to 65
  • Fluent in English
  • Have the competency for fully informed consent by 6 months post-injury
  • Have basic computer skills
  • Have functional use of one upper extremity
  • Have access to the internet

You may not qualify if:

  • A neurological disorder other than TBI (e.g., stroke, dementia, tumor, neurodevelopmental disorder) impairing baseline awareness, cognition, or validity of follow-up and outcome assessment.
  • A systemic condition (e.g., lupus, diabetes, rheumatoid arthritis).
  • Any contraindications to magnetic resonance imaging (MRI)
  • You are experiencing language impairments (i.e., aphasia) from your injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Vancouver General Hopsital

Vancouver, British Columbia, V5Z 1M9, Canada

ENROLLING BY INVITATION

GF Strong Rehabilitation Centre

Vancouver, British Columbia, V5Z 2G9, Canada

RECRUITING

MeSH Terms

Conditions

Brain Injuries, TraumaticLymphoma, Follicular

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • William Panenka, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Robin Green, PhD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nishtha Parag, BSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The psychometrist will be blind to the arm the participant is assigned to.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized two-armed study, comprised of a treatment arm and a control arm. Given the small numbers and the potentially slow rate of recruitment, the investigators will employ simple rather than block randomization. To minimize selection bias, allocation to group will be concealed (i.e., with assignment unpredictable and unchangeable) using software that randomizes each patient upon confirmation of eligibility. Patients will not be blind to group assignment, but the psychometrist completing behavioural outcomes will be kept blind to group assignment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 3, 2018

First Posted

November 1, 2018

Study Start

July 25, 2019

Primary Completion

July 1, 2023

Study Completion

July 1, 2024

Last Updated

May 9, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations